We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Eli Lilly and Company | NEO:LLY | NEO | Depository Receipt |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -0.17% | 28.99 | 28.78 | 30.28 | 29.38 | 28.80 | 29.00 | 57,290 | 22:30:01 |
10:09 ET -- Eli Lilly is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. Lilly launched a direct-to-consumer website Thursday, as the company stepped up its marketing efforts for weight-loss drugs. The company's LillyDirect will connect U.S. patients living with migraine, diabetes or obesity with independent doctors and support, and deliver some Lilly medicines through third-party pharmacies to a patient's home. Dow Jones & Co. owns Factiva. (chris.wack@wsj.com)
(END) Dow Jones Newswires
January 05, 2024 10:24 ET (15:24 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
1 Year Eli Lilly Chart |
1 Month Eli Lilly Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions